Filing Flows › Korsana Biosciences (KRSA) › Next earnings date
Korsana Biosciences (KRSA) earnings: missed the estimate
Korsana Biosciences (KRSA) reported on Nov 5, 2026 and missed the EPS estimate: −$3.19 against −$0.67 (-372.8%). It beat the EPS estimate in 50% of the quarters on record.
The last report
Korsana Biosciences reported revenue of $1.0M for the fourth quarter 2025 (-43% Y/Y), net loss $799K. How it makes money → · Every quarter →
Korsana Biosciences' latest quarter
Korsana Biosciences, Q4 2025: revenue $1.0M (-43% year over year), operating margin -81.8%, net loss $799K, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
Questions
Did Korsana Biosciences beat earnings?
Korsana Biosciences (KRSA) reported on Nov 5, 2026 and missed the EPS estimate: −$3.19 against −$0.67 (-372.8%).
When does KRSA report earnings?
The next date is not set yet.
Does Korsana Biosciences usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.